{
    "Trade/Device Name(s)": [
        "Immunalysis Opiates Urine Enzyme Immunoassay",
        "Immunalysis Opiates Urine Calibrators 300",
        "Immunalysis Multi-Drug Controls",
        "Immunalysis Opiates Urine Calibrators 2000"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K143502",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051088",
        "K011150"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "DIF"
    ],
    "Summary Letter Date": "March 26, 2015",
    "Summary Letter Received Date": "March 27, 2015",
    "Submission Date": "May 18, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Clinical Toxicology Calibrator",
        "Clinical Toxicology Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Morphine",
        "Benzoylecgonine",
        "Methadone",
        "Methamphetamine",
        "PCP",
        "Secobarbital",
        "Oxazepam"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU 400e",
        "Agilent 1200 Series Liquid Chromatograph",
        "Agilent 6410/6430 Tandem Mass Spectrometer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Gas Chromatography/Mass Spectrometry (GC-MS)",
        "Liquid Chromatography/Mass Spectrometry (LC/MS)"
    ],
    "Methodologies": [
        "Homogeneous enzyme immunoassay",
        "Mass spectrometry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Opiates Urine Enzyme Immunoassay, calibrators, and multi-drug controls for detection and monitoring of opiates and other drugs in human urine using automated clinical chemistry analyzers",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of opiates in human urine for laboratory use with automated clinical chemistry analyzers; calibrators and controls for calibration and performance monitoring of assays for morphine and other drugs.",
    "fda_folder": "Toxicology"
}